On Friday, Soleno Therapeutics Inc (NASDAQ: SLNO) opened lower -3.00% from the last session, before settling in for the closing price of $75.62. Price fluctuations for SLNO have ranged from $36.93 to $80.99 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 36.23% at the time writing. With a float of $41.69 million, this company’s outstanding shares have now reached $48.53 million.
The firm has a total of 92 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Soleno Therapeutics Inc (SLNO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Soleno Therapeutics Inc is 17.28%, while institutional ownership is 95.11%. The most recent insider transaction that took place on Apr 01 ’25, was worth 265,156. In this transaction an insider of this company sold 3,782 shares at a rate of $70.11, taking the stock ownership to the 27,036 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Officer proposed sale 3,782 for $70.11, making the entire transaction worth $265,156.
Soleno Therapeutics Inc (SLNO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 36.23% per share during the next fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Check out the current performance indicators for Soleno Therapeutics Inc (SLNO). In the past quarter, the stock posted a quick ratio of 19.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.62, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach 0.80 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Analysing the last 5-days average volume posted by the [Soleno Therapeutics Inc, SLNO], we can find that recorded value of 0.7 million was lower than the volume posted last year of 0.99 million. As of the previous 9 days, the stock’s Stochastic %D was 45.58%. Additionally, its Average True Range was 3.05.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 80.65%, which indicates a significant increase from 27.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.16% in the past 14 days, which was lower than the 74.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.07, while its 200-day Moving Average is $54.84. Now, the first resistance to watch is $74.89. This is followed by the second major resistance level at $76.42. The third major resistance level sits at $77.57. If the price goes on to break the first support level at $72.20, it is likely to go to the next support level at $71.05. Now, if the price goes above the second support level, the third support stands at $69.52.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
There are currently 50,394K shares outstanding in the company with a market cap of 3.70 billion. Presently, the company’s annual sales total 0 K according to its annual income of -175,850 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -43,770 K.
